Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of INM will decline by -24.94% over the next 2 Weeks and hit $1.20 by Tuesday, June 2, 2026. In that time frame, INM's share price is expected to range between $1.05 and $1.33.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jun 2, 2026 | 1.05 | 1.20 | 1.33 |
| Jun 1, 2026 | 0.93 | 1.08 | 1.21 |
| May 29, 2026 | 0.98 | 1.12 | 1.25 |
| May 28, 2026 | 1.00 | 1.14 | 1.28 |
| May 27, 2026 | 0.99 | 1.14 | 1.28 |
| May 26, 2026 | 1.06 | 1.20 | 1.34 |
| May 25, 2026 | 0.94 | 1.08 | 1.23 |
| May 22, 2026 | 0.98 | 1.12 | 1.26 |
| May 21, 2026 | 0.99 | 1.14 | 1.29 |
| May 20, 2026 | 1.00 | 1.14 | 1.28 |
INM shares rose +135.05% in Tuesday, May 19, 2026's trading session, rising from a previous close of $0.68 to move at $1.60. The stock demonstrated notable intraday movement (see INM's key stats for a full breakdown), fluctuating between $1.31 and $1.79, a +36.64% trading range. While recent weeks have seen some volatility, INM has managed to secure a +120.26% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 92.46M shares changing hands, 92.45M more than the previous session. This amounted to $147.94M in total market activity.
Will INM Continue Its Downward Trend?
According to analyst ratings and projections for INM, InMed Pharmaceuticals Inc. shares are anticipated to decrease by -20.37%, potentially reaching $1.33 per share by June 2, 2026. Short-term technical indicators for INM currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 17 negative trading days within the past 30 sessions. Based on the INM stock forecast, now is not the best time to buy INM stock because its current trading price is +33.23% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on INM covering social and institutional perspectives.
INM Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into INM's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 81.65% to 91.36%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 62.84%, suggests strong medium-term momentum. However, the 100-day RSI, at 50.85%, maintains a neutral outlook for the long term. Insights into INM's shareholder base show how institutional investors are positioning themselves during these momentum shifts
InMed Pharmaceuticals Short-Term Forecasts
INM Forecast For Next 5 Days
Our algorithm anticipates InMed Pharmaceuticals (INM) stock could hit $0.63 by May 26, 2026. This represents a -60.68% fall from today's price, following a -8.55% change over the past five days.
INM Forecast For Next 30 Days
Based on analysis of market trends, the outlook for InMed Pharmaceuticals Inc. (INM) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.60, which would mean a -62.50% decrease from the current price of $1.60. Projections for this period range from a high of $0.73 to a low of $0.49.
INM Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for InMed Pharmaceuticals's price over the next three months point to a rise. INM stock is expected to peak at $2.13 on May 20, 2026 before potentially dipping to $1.07 on Aug 17, 2026. On average, INM is likely to trade around $1.62 in the coming 90 days.
InMed Pharmaceuticals Stock Forecast 2025
Based on our predictive models, InMed Pharmaceuticals (INM) is expected to trade between $0.40 and $2.13 throughout 2026. This would result in an average price of $1.30, potentially offering investors a -18.75% return from current levels.
InMed Pharmaceuticals Inc. Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, InMed Pharmaceuticals Inc. (INM) is positioned to show a strong performance in May 2026. The price is predicted to move between $1.31 and $2.13, settling at an average of $1.73. This could translate to a +8.12% gain.
June 2026
Based on current market signals, InMed Pharmaceuticals Inc. is projected to trend june 2026. We forecast a trading range from $1.19 to $2.04, with a likely average price of $1.62. Investors could expect a potential return of +1.25%.
July 2026
Our predictive algorithms indicate InMed Pharmaceuticals Inc. stock may see a shift in July 2026. The expected range spans $1.21–$2.10, with an average target of $1.65. This represents a positive outlook and a possible gain of +3.12%.
August 2026
Analyzing established trends, InMed Pharmaceuticals Inc. looks set to move in August 2026. Projections place the stock between $1.00 and $2.03, averaging around $1.47. This suggests a -8.13% loss from current levels.
September 2026
Market indicators suggest InMed Pharmaceuticals Inc. could experience notable changes during September 2026. Prices could fluctuate within $0.92 to $1.86, with a midpoint forecast of $1.40. The stock might deliver a -12.50% loss.
October 2026
Forecasting for October 2026, models estimate that InMed Pharmaceuticals Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.61 and $1.57, averaging $1.12. This signals a cautious trajectory with potential returns around -30.00%.
November 2026
According to our latest forecast models, InMed Pharmaceuticals Inc. (INM) is positioned to show a strong performance in November 2026. The price is predicted to move between $0.41 and $1.30, settling at an average of $0.86. This could translate to a -46.25% loss.
December 2026
Based on current market signals, InMed Pharmaceuticals Inc. is projected to trend december 2026. We forecast a trading range from $0.40 to $1.31, with a likely average price of $0.84. Investors could expect a potential return of -47.50%.
January 2027
Our predictive algorithms indicate InMed Pharmaceuticals Inc. stock may see a shift in January 2027. The expected range spans $0.21–$1.16, with an average target of $0.72. This represents a cautious outlook and a possible loss of -55.00%.
February 2027
Analyzing established trends, InMed Pharmaceuticals Inc. looks set to move in February 2027. Projections place the stock between $0.17 and $1.01, averaging around $0.63. This suggests a -60.63% loss from current levels.
March 2027
Market indicators suggest InMed Pharmaceuticals Inc. could experience notable changes during March 2027. Prices could fluctuate within $0.04 to $0.92, with a midpoint forecast of $0.52. The stock might deliver a -67.50% loss.
April 2027
Forecasting for April 2027, models estimate that InMed Pharmaceuticals Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.82, averaging $0.48. This signals a cautious trajectory with potential returns around -70.00%.
May 2027
According to our latest forecast models, InMed Pharmaceuticals Inc. (INM) is positioned to show a strong performance in May 2027. The price is predicted to move between $0.00 and $0.77, settling at an average of $0.47. This could translate to a -70.62% loss.
INM's history of dividends and stock splits also plays a role in long-term investor confidence.

